Subclinical atherosclerosis and arterial stiffness in nonalcoholic fatty liver disease: A case-control study in Algerian population

Ludwig, 1980, Nonalcoholic steatohepatitis: Mayo Clinic experiences with a hitherto unnamed disease, Mayo Clin Proc, 55, 434 Blachier, 2013, The burden of liver disease in Europe: a review of available epidemiological data, J Hepatol, 58, 593, 10.1016/j.jhep.2012.12.005 Kanwal, 2016, Trends in the Burden of Nonalcoholic Fatty Liver Disease in a United States Cohort of Veterans, Clin Gastroenterol Hepatol, 14, 10.1016/j.cgh.2015.08.010 Younossi, 2011, Changes in the prevalence of the most common causes of chronic liver diseases in the United States from 1988 to 2008, Clin Gastroenterol Hepatol, 9 De, 2020, Natural History of Simple Steatosis or Nonalcoholic Fatty Liver, J Clin Exp Hepatol, 10, 255, 10.1016/j.jceh.2019.09.005 Chalasani, 2012, The diagnosis and management of non-alcoholic fatty liver disease: practice Guideline by the American Association for the Study of Liver Diseases, American College of Gastroenterology, and the American Gastroenterological Association, Hepatology, 55, 2005, 10.1002/hep.25762 Chacko, 2016, Extrahepatic Complications of Nonalcoholic Fatty Liver Disease, Clin Liver Dis, 20, 387, 10.1016/j.cld.2015.10.004 Ahmed, 2012, Nonalcoholic fatty liver disease and cardiovascular disease: has the time come for cardiologists to be hepatologists?, J Obes, 2012, 483135, 10.1155/2012/483135 Lonardo, 2016, Non-alcoholic fatty liver disease and risk of cardiovascular disease, Metabolism, 65, 1136, 10.1016/j.metabol.2015.09.017 Anstee, 2013, Progression of NAFLD to diabetes mellitus, cardiovascular disease or cirrhosis, Nat Rev Gastroenterol Hepatol, 10, 330, 10.1038/nrgastro.2013.41 Targher, 2011, Risk of cardiovascular disease and chronic kidney disease in diabetic patients with non-alcoholic fatty liver disease: just a coincidence?, J Endocrinol Invest, 34, 544 Buzzetti, 2016, The multiple-hit pathogenesis of non-alcoholic fatty liver disease (NAFLD), Metabolism, 65, 1038, 10.1016/j.metabol.2015.12.012 Touboul, 2012, Cerebrovasc Dis, 34, 290, 10.1159/000343145 Wong, 2012, Liver stiffness measurement using XL probe in patients with nonalcoholic fatty liver disease, Am J Gastroenterol, 107, 1862, 10.1038/ajg.2012.331 Barbosa, 2014 Mancia, 2013, 2013 ESH/ESC guidelines for the management of arterial hypertension: the Task Force for the Management of Arterial Hypertension of the European Society of Hypertension (ESH) and of the European Society of Cardiology (ESC), Eur Heart J, 34, 2159, 10.1093/eurheartj/eht151 Mulvagh, 2008, American Society of Echocardiography Consensus Statement on the Clinical Applications of Ultrasonic Contrast Agents in Echocardiography, J Am Soc Echocardiogr, 21, 1179, 10.1016/j.echo.2008.09.009 Matthews, 1985, Homeostasis model assessment: insulin resistance and β-cell function from fasting plasma glucose and insulin concentrations in man, Diabetologia, 28, 412, 10.1007/BF00280883 2001, Executive Summary of The Third Report of The National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, And Treatment of High Blood Cholesterol In Adults (Adult Treatment Panel III), JAMA, 285, 2486, 10.1001/jama.285.19.2486 Alberti, 2005, consensus worldwide definition of the metabolic syndrome, Lancet, 366, 1059, 10.1016/S0140-6736(05)67402-8 Wilson, 1998, Prediction of coronary heart disease using risk factor categories, Circulation, 97, 1837, 10.1161/01.CIR.97.18.1837 Boutouyrie, 2010, Determinants of pulse wave velocity in healthy people and in the presence of cardiovascular risk factors: “establishing normal and reference values”, Eur Heart J, 31, 2338, 10.1093/eurheartj/ehq165 Norgren, 2007, Inter-Society Consensus for the Management of Peripheral Arterial Disease (TASC II), Eur J Vascular Endovasc Surg, 33, S1, 10.1016/j.ejvs.2006.09.024 Laurent, 2013 Townsend, 2017, Arterial Stiffness: Recommendations and Standardization, Pulse (Basel, Switzerland), 4, 3 Fracanzani, 2008, Carotid artery intima-media thickness in nonalcoholic fatty liver disease, Am J Med, 121, 72, 10.1016/j.amjmed.2007.08.041 Lorenz, 2007, Prediction of clinical cardiovascular events with carotid intima-media thickness: a systematic review and meta-analysis, Circulation, 115, 459, 10.1161/CIRCULATIONAHA.106.628875 Shoji, 2000, Additive impacts of diabetes and renal failure on carotid atherosclerosis, Atherosclerosis, 153, 257, 10.1016/S0021-9150(00)00529-3 Benedetto, 2001, Prognostic value of ultrasonographic measurement of carotid intima media thickness in dialysis patients, J Am Soc Nephrol, 12, 2458, 10.1681/ASN.V12112458 Brea, 2005, Nonalcoholic fatty liver disease is associated with carotid atherosclerosis: a case-control study, Arterioscler Thromb Vasc Biol, 25, 1045, 10.1161/01.ATV.0000160613.57985.18 Cai, 2015, Association between nonalcoholic fatty liver disease and carotid atherosclerosis: a meta-analysis, Int J Clin Exp Med, 8, 7673 Mohammadi, 2011, Evaluation of carotid intima-media thickness and flow-mediated dilatation in middle-aged patients with nonalcoholic fatty liver disease, Vasc Health Risk Manag, 7, 661 Targher, 2004, Relation of nonalcoholic hepatic steatosis to early carotid atherosclerosis in healthy men: role of visceral fat accumulation, Diabetes Care, 27, 2498, 10.2337/diacare.27.10.2498 2018 Cortez-Pinto, 1999, Non-alcoholic fatty liver: another feature of the metabolic syndrome?, Clin Nutr, 18, 353, 10.1016/S0261-5614(99)80015-6 Marchesini, 1999, Association of nonalcoholic fatty liver disease with insulin resistance, Am J Med, 107, 450, 10.1016/S0002-9343(99)00271-5 Redon, 2016, Global Cardiovascular Risk Assessment: Strengths and Limitations, High Blood Press Cardiovasc Prev, 23, 87, 10.1007/s40292-016-0139-2 Kang, 2012, Relationship between Nonalcoholic Fatty Liver Disease and Carotid Artery Atherosclerosis Beyond Metabolic Disorders in Non-Diabetic Patients, J Cardiovasc Ultrasound, 20, 126, 10.4250/jcu.2012.20.3.126 Denarié, 2000, Distribution of ultrasonographically-assessed dimensions of common carotid arteries in healthy adults of both sexes, Atherosclerosis, 148, 297, 10.1016/S0021-9150(99)00276-2 Simon, 2002, Intima-media thickness: a new tool for diagnosis and treatment of cardiovascular risk, J Hypertens, 20, 159, 10.1097/00004872-200202000-00001 Ben-Shlomo, 2014, Aortic pulse wave velocity improves cardiovascular event prediction: an individual participant meta-analysis of prospective observational data from 17,635 subjects, J Am Coll Cardiol, 63, 636, 10.1016/j.jacc.2013.09.063 Vlachopoulos, 2010, Prediction of cardiovascular events and all-cause mortality with arterial stiffness: a systematic review and meta-analysis, J Am Coll Cardiol, 55, 1318, 10.1016/j.jacc.2009.10.061 Salvi, 2010, Increased arterial stiffness in nonalcoholic fatty liver disease: the Cardio-GOOSE study, J Hypertens, 28, 1699, 10.1097/HJH.0b013e32833a7de6 Xin, 2020, Associations of subclinical atherosclerosis with nonalcoholic fatty liver disease and fibrosis assessed by non-invasive score, Liver Int, 40, 806, 10.1111/liv.14322 Chen, 2015, Advanced fibrosis associates with atherosclerosis in subjects with nonalcoholic fatty liver disease, Atherosclerosis, 241, 145, 10.1016/j.atherosclerosis.2015.05.002 Lombardi, 2020, Liver fibrosis by FibroScan((R)) independently of established cardiovascular risk parameters associates with macrovascular and microvascular complications in patients with type 2 diabetes, Liver Int, 40, 347, 10.1111/liv.14274 Sunbul, 2014, Arterial stiffness in patients with non-alcoholic fatty liver disease is related to fibrosis stage and epicardial adipose tissue thickness, Atherosclerosis, 237, 490, 10.1016/j.atherosclerosis.2014.10.004 Omelchenko, 2014, Adiponectin is better predictor of subclinical atherosclerosis than liver function tests in patients with nonalcoholic fatty liver disease, J Am Soc Hypertens, 8, 376, 10.1016/j.jash.2014.03.002 Jain, 2014, Inflammation and arterial stiffness in humans”, Atherosclerosis., 237, 381, 10.1016/j.atherosclerosis.2014.09.011 Fargion, 2014, Nonalcoholic fatty liver disease and vascular disease: state-of-the-art, World J Gastroenterol, 20, 13306, 10.3748/wjg.v20.i37.13306 Villela-Nogueira, 2016, NAFLD and Increased Aortic Stiffness: Parallel or Common Physiopathological Mechanisms?, Int J Mol Sci, 17, 460, 10.3390/ijms17040460 Lin, 2013, The ankle-brachial index for peripheral artery disease screening and cardiovascular disease prediction among asymptomatic adults: a systematic evidence review for the U.S. Preventive Services Task Force, Ann Intern Med, 159, 333, 10.7326/0003-4819-159-5-201309030-00007 Vasunta, 2012, High ambulatory blood pressure values associated with non-alcoholic fatty liver in middle-aged adults, J Hypertens, 30, 2015, 10.1097/HJH.0b013e3283576faf Kasper, 2020, NAFLD and cardiovascular diseases: a clinical review, Clin Res Cardiol, 10.1007/s00392-020-01709-7 López-Suárez, 2011, Nonalcoholic fatty liver disease is associated with blood pressure in hypertensive and nonhypertensive individuals from the general population with normal levels of alanine aminotransferase, Eur J Gastroenterol Hepatol, 23, 1011, 10.1097/MEG.0b013e32834b8d52 Lorbeer, 2017, Association between MRI-derived hepatic fat fraction and blood pressure in participants without history of cardiovascular disease, J Hypertens, 35, 737, 10.1097/HJH.0000000000001245 Lau, 2010, The association between fatty liver disease and blood pressure in a population-based prospective longitudinal study, J Hypertens, 28, 1829, 10.1097/HJH.0b013e32833c211b Aneni, 2015, Blood pressure is associated with the presence and severity of nonalcoholic fatty liver disease across the spectrum of cardiometabolic risk, J Hypertens, 33, 1207, 10.1097/HJH.0000000000000532 Ciardullo, 2020, Nonalcoholic Fatty Liver Disease and Advanced Fibrosis in US Adults Across Blood Pressure Categories, Hypertension, 76, 562, 10.1161/HYPERTENSIONAHA.120.15220 Kanwal, 2020, Effect of Metabolic Traits on the Risk of Cirrhosis and Hepatocellular Cancer in Nonalcoholic Fatty Liver Disease, Hepatology, 71, 808, 10.1002/hep.31014 Singh, 2015, Fibrosis progression in nonalcoholic fatty liver vs nonalcoholic steatohepatitis: a systematic review and meta-analysis of paired-biopsy studies, Clin Gastroenterol Hepatol, 13, 10.1016/j.cgh.2014.04.014 Ridker, 2003, C-reactive protein and risk of cardiovascular disease: Evidence and clinical application, Curr Atheroscler Rep, 5, 341, 10.1007/s11883-003-0004-3 Upadhyay, 2015, Emerging risk biomarkers in cardiovascular diseases and disorders, J Lipids, 2015, 971453, 10.1155/2015/971453 Yeboah, 2016, Utility of Nontraditional Risk Markers in Atherosclerotic Cardiovascular Disease Risk Assessment, J Am Coll Cardiol, 67, 139, 10.1016/j.jacc.2015.10.058 Kunutsor, 2014, Liver enzymes and risk of cardiovascular disease in the general population: a meta-analysis of prospective cohort studies, Atherosclerosis, 236, 7, 10.1016/j.atherosclerosis.2014.06.006 Wannamethee, 2008, The value of gamma-glutamyltransferase in cardiovascular risk prediction in men without diagnosed cardiovascular disease or diabetes, Atherosclerosis, 201, 168, 10.1016/j.atherosclerosis.2008.01.019 Sanyal, 2015, Profile of liver enzymes in non-alcoholic fatty liver disease in patients with impaired glucose tolerance and newly detected untreated type 2 diabetes, Indian J Endocrinol Metab, 19, 597, 10.4103/2230-8210.163172 Bedossa, 2013, Current histological classification of NAFLD: strength and limitations, Hepatol Int, 7, 765, 10.1007/s12072-013-9446-z